'Goal is to offer more innovative medicines'

Eli Lilly plans to turn India into a growth market by addressing its diabetes and obesity challenges with its new treatment, Mounjaro. CEO David Ricks is optimistic about India's growth potential and highlights the transformative power of innovative medicines alongside generics in managing public health.

from Business News: Budget 2025, Business News Today, Latest Business News, Stock Markets, Financial News, India Business & World Business News https://ift.tt/8cgEN42
>

Comments

Popular posts from this blog

“It felt right to make my comeback with my dad’s song, ‘Woh Beete Din’”, says Tanya Kumar who will soon be making a comeback to music

Patym parent co president and COO quits